Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

442

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

ARQ-151 0.3% cream

ARQ-151 0.3% cream

DRUG

ARQ-151 vehicle cream

ARQ-151 vehicle cream

Trial Locations (39)

19008

Arcutis Biotherapeutics Clinical Site 229, Broomall

23220

Arcutis Biotherapeutics Clinical Site 230, Richmond

32720

Arcutis Biotherapeutics Clinical Site 237, DeLand

33162

Arcutis Biotherapeutics Clinical Site 201, North Miami Beach

33172

Arcutis Biotherapeutics Clinical Site 209, Sweetwater

33770

Arcutis Biotherapeutics Clinical Site 228, Largo

37130

Arcutis Biotherapeutics Clinical Site 221, Murfreesboro

37922

Arcutis Biotherapeutics Clinical Site 233, Knoxville

40217

Arcutis Biotherapeutics Clinical Site 217, Louisville

46250

Arcutis Biotherapeutics Clinical Site 214, Indianapolis

48202

Arcutis Biotherapeutics Clinical Site 212, Detroit

55432

Arcutis Biotherapeutics Clinical Site 216, Fridley

64506

Arcutis Biotherapeutics Clinical Site 227, Saint Joseph

70006

Arcutis Biotherapeutics Clinical Site 213, Metairie

70115

Arcutis Biotherapeutics Clinical Site 224, New Orleans

70605

Arcutis Biotherapeutics Clinical Site 211, Lake Charles

73112

Arcutis Biotherapeutics Clinical Site 222, Oklahoma City

76011

Arcutis Biotherapeutics Clinical Site 206, Arlington

77030

Arcutis Biotherapeutics Clinical Site 238, Houston

84088

Arcutis Biotherapeutics Clinical Site 210, West Jordan

85255

Arcutis Biotherapeutics Clinical Site 203, Scottsdale

89148

Arcutis Biotherapeutics Clinical Site 219, Las Vegas

Arcutis Biotherapeutics Clinical Site 231, Las Vegas

89703

Arcutis Biotherapeutics Clinical Site 240, Reno

90212

Arcutis Biotherapeutics Clinical Site 239, Beverly Hills

90404

Arcutis Biotherapeutics Clinical Site 208, Santa Monica

90503

Arcutis Biotherapeutics Clinical Site 215, Santa Monica

91436

Arcutis Biotherapeutics Clinical Site 225, Encino

Arcutis Biotherapeutics Clinical Site 223, Boynton Beach

92123

Arcutis Biotherapeutics Clinical Site 220, San Diego

03801

Arcutis Biotherapeutics Clinical Site 236, Portsmouth

V3R 6A7

Arcutis Biotherapeutics Clinical Site 207, Surrey

V3V0C6

Arcutis Biotherapeutics Clinical Site 226, Surrey

R3M 3Z4

Arcutis Biotherapeutics Clinical Site 232, Winnepeg

E3B 1G9

Arcutis Biotherapeutics Clinical Site 234, Fredericton

L1S 7K8

Arcutis Biotherapeutics Clinical Site 205, Ajax

L4M 7G1

Arcutis Biotherapeutics Clinical Site 218, Barrie

M4W 2N2

Arcutis Biotherapeutics Clinical Site 235, Toronto

N8W 1E6

Arcutis Biotherapeutics Clinical Site 204, Windsor

Sponsors
All Listed Sponsors
lead

Arcutis Biotherapeutics, Inc.

INDUSTRY

NCT04211389 - Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | Biotech Hunter | Biotech Hunter